Combined use of subclinical hydroxyurea and CHK1 inhibitor effectively controls melanoma and lung cancer progression, with reduced normal tissue toxicity compared to gemcitabine
| Image |  |
|---|---|
| Description | scientific article published on 14 June 2019 |
| Author/s |
author: Nikolas K. Haass Vanessa F Bonazzi Deborah Nazareth Sebastian Walpole Alexander J Stevenson Brian Gabrielli |
| Publication date | June 14, 2019 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |